Your browser doesn't support javascript.
loading
Adherence to Iron Chelation Therapy Among Children with Beta Thalassemia Major: A Multicenter Cross-Sectional Study.
Keowmani, Thamron; Teo, Siew Chin; Yap, Kuan Chau; Chua, Wei Lian; Mohd Tahir, Nur Farahanim; Chua, Peck Wei; Lim, V Co; Leong, Hoon Hing.
Afiliación
  • Keowmani T; Pharmacy Department, Hospital Wanita Dan Kanak-Kanak Sabah, Sabah, Malaysia.
  • Teo SC; Pharmacy Department, Hospital Wanita Dan Kanak-Kanak Sabah, Sabah, Malaysia.
  • Yap KC; Pharmacy Department, Hospital Tunku Azizah, Kuala Lumpur, Malaysia.
  • Chua WL; Pharmacy Department, Hospital Raja Perempuan Zainab II, Kelantan, Malaysia.
  • Mohd Tahir NF; Pharmacy Department, Hospital Melaka, Melaka, Malaysia.
  • Chua PW; Pharmacy Department, Hospital Tengku Ampuan Afzan, Pahang, Malaysia.
  • Lim VC; Pharmacy Department, Hospital Ampang, Selangor, Malaysia.
  • Leong HH; Pharmacy Department, Hospital Queen Elizabeth, Sabah, Malaysia.
Hemoglobin ; 47(6): 237-244, 2023 Nov.
Article en En | MEDLINE | ID: mdl-38111324
ABSTRACT

BACKGROUND:

Adherence to iron chelation therapy (ICT) remains an issue among thalassemia patients. This study aimed to determine the prevalence of non-adherence to ICT among children with beta thalassemia major in Malaysia and the factors associated with it.

METHODS:

This was a cross-sectional study conducted between November 2019 and November 2021 at seven tertiary hospitals in Malaysia. Participants registered with Malaysian Thalassemia Registry were recruited by convenience sampling. Adherence was measured via pill count and self-reported adherence. Knowledge about thalassemia and ICT was measured using a questionnaire from Modul Thalassemia by Ministry of Health of Malaysia. A decision tree was used to identify predictors of non-adherence.

RESULTS:

A total of 135 patients were recruited. The prevalence of non-adherence to ICT in those who took subcutaneous ± oral medications was 47.5% (95% CI 31.5%, 63.9%) and the prevalence of non-adherence to ICT in those who took oral medications only was 21.1% (95% CI 13.4%, 30.6%). The median knowledge score was 67.5% (IQR 15%). A decision tree has identified two factors associated with non-adherence. They were ICT's route of administration and knowledge score. Out of 100 patients who were on oral medications only, 79 were expected to adhere. Out of 100 patients who were on subcutaneous ± oral medications and scored less than 56.25% in knowledge questionnaire, 86 were expected to non-adhere. Based on the logistic regression, the odds of non-adherence in patients who took oral medications only was 71% lower than the odds of non-adherence in patients who took subcutaneous ± oral medications (OR = 0.29; 95% CI = 0.13, 0.65; p = .002).

CONCLUSION:

The prevalence of non-adherence to ICT among children with beta thalassemia major in Malaysia was 20/95 (21.1%) in those who took oral medications only and the prevalence of non-adherence was 19/40 (47.5%) in those who took subcutaneous ± oral medications. The factors associated with non-adherence were ICT's route of administration and knowledge score.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Talasemia / Talasemia beta / Sobrecarga de Hierro Límite: Child / Humans Idioma: En Revista: Hemoglobin Año: 2023 Tipo del documento: Article País de afiliación: Malasia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Talasemia / Talasemia beta / Sobrecarga de Hierro Límite: Child / Humans Idioma: En Revista: Hemoglobin Año: 2023 Tipo del documento: Article País de afiliación: Malasia